文献
J-GLOBAL ID:201802235017932253
整理番号:18A0258413
神経科医と多発性硬化症患者の大規模コホートにおけるナタリズマブ療法の損益の認識【Powered by NICT】
Benefit-risk perception of natalizumab therapy in neurologists and a large cohort of multiple sclerosis patients
著者 (7件):
Heesen Christoph
(Institut fuer Neuroimmunologie und Multiple Sklerose (INIMS), Universitaetsklinikum Hamburg-Eppendorf, Martinistr. 52, 2046 Hamburg, Germany)
,
Kleiter Ingo
(Department of Neurology, St. Josef-Hospital, Ruhr-University-Bochum, Gudrunstr. 56, 44791 Bochum, Germany)
,
Meuth Sven G.
(Department of Neurology, Neurology Clinic and Institute of Translational Neurology, Westfaelische Wilhelms University, Albert Schweizer Campus 1, 48149 Muenster, Germany)
,
Kraemer Julia
(Department of Neurology, Neurology Clinic and Institute of Translational Neurology, Westfaelische Wilhelms University, Albert Schweizer Campus 1, 48149 Muenster, Germany)
,
Kasper Juergen
(Department of Health and Caring Sciences, Faculty of Health Sciences, University of Tromso, Hansine Hansens veg 18, 9019 Tromso, Norway)
,
Kopke Sascha
(Institute of Social Medicine, University Hospital Schleswig-Holstein, Ratzeburger Allee 160, 23538 Luebeck, Germany)
,
Gaissmaier Wolfgang
(Department of Psychology, University of Konstanz, Universitaetsstrasse 10, 78464 Konstanz, Germany)
資料名:
Journal of the Neurological Sciences
(Journal of the Neurological Sciences)
巻:
376
ページ:
181-190
発行年:
2017年
JST資料番号:
A1131A
ISSN:
0022-510X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)